Search Results - Vanderhoek, Louise

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six‐month, randomized, double‐blind, placebo‐controlled, proof‐of‐concept pilot study at a single center

    Imatinib in active diffuse cutaneous systemic sclerosis: Results of a six‐month, randomized, double‐blind, placebo‐controlled, proof‐of‐concept pilot study at a single center... by Pope, Janet, McBain, Donna, Petrlich, Lisa, Watson, Sharon, Vanderhoek, Louise, de Leon, Faye, Seney, Shannon, Summers, Kelly

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Brentuximab vedotin compared to historical controls for severe skin involvement in cutaneous systemic sclerosis

    Brentuximab vedotin compared to historical controls for severe skin involvement in cutaneous systemic sclerosis by Fernández-Codina, Andreu, Nevskaya, Tatiana, Baron, Murray, Appleton, C Thomas, Cecchini, Matthew J, Philip, Amanda, El-Shimy, Maha, Vanderhoek, Louise, Pinal-Fernández, Iago, Pope, Janet E

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis

    Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosis by Fernández-Codina, Andreu, Nevskaya, Tatiana, Baron, Murray, Appleton, C Thomas, Cecchini, Matthew J, Philip, Amanda, El-Shimy, Maha, Vanderhoek, Louise, Pinal-Fernández, Iago, Pope, Janet E

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial

    Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial by Fernández-Codina, Andreu, Nevskaya, Tatiana, Baron, Murray, Thomas Appleton, C, Cecchini, Matthew J, Philip, Amanda, El-Shimy, Maha, Vanderhoek, Louise, Pinal-Fernández, Iago, Pope, Janet E

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study

    Correlations between changes in cytokines and clinical outcomes for early phase (proof of concept) trials in active diffuse systemic sclerosis using data from an imatinib study by Pope, Janet, Walker, Kyle M, de Leon, Faye, Vanderhoek, Louise, Seney, Shannon, Summers, Kelly L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    A randomized, single-blinded cross-over trial of ischemic preconditioning in Raynaud's phenomenon

    A randomized, single-blinded cross-over trial of ischemic preconditioning in Raynaud's phenomenon by Neferu, Ramona, Vanderhoek, Louise, Hewitt, Sara, Nevskaya, Tatiana, Pope, Janet E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Results of a Pilot Randomized Placebo-Controlled Trial in Primary and Secondary Raynaud's Phenomenon with St. John's Wort : Detecting Changes in Angiogenic Cytokines When RP Improves

    Results of a Pilot Randomized Placebo-Controlled Trial in Primary and Secondary Raynaud's Phenomenon with St. John's Wort : Detecting Changes in Angiogenic Cytokines When RP Improv... by Summers, Kelly, Malenfant, Déanne, Seney, Shannon, McBain, Donna, Petrlich, Lisa, Watson, Sharon, Vanderhoek, Louise, Samadi, Nooshin, Bonner, Ashley, Pope, Janet

    Published in ISRN rheumatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: